Literature DB >> 34848832

Development and validation of a vascularity-based architectural classification for clear cell renal cell carcinoma: correlation with conventional pathological prognostic factors, gene expression patterns, and clinical outcomes.

Chisato Ohe1, Takashi Yoshida2, Mahul B Amin3,4, Naho Atsumi5, Junichi Ikeda5,2, Kazuho Saiga5, Yuri Noda5, Yoshiki Yasukochi6, Riuko Ohashi7, Haruyuki Ohsugi2, Koichiro Higasa6, Hidefumi Kinoshita2, Koji Tsuta5.   

Abstract

The prognostic significance of an architectural grading system for clear cell renal cell carcinoma (ccRCC) has recently been demonstrated. The present study aimed to establish a vascularity-based architectural classification using the cohort of 436 patients with localized ccRCC who underwent extirpative surgery and correlated the findings with conventional pathologic factors, gene expression, and prognosis. First, we assessed architectural patterns in the highest-grade area on hematoxylin and eosin-stained slides, then separately evaluated our surrogate score for vascularity. We grouped nine architectural patterns into three categories based on the vascular network score. "Vascularity-based architectural classification" was defined: category 1: characterized by enrichment of the vascular network, including compact/small nested, macrocyst/microcystic, and tubular/acinar patterns; category 2: characterized by a widely spaced-out vascular network, including alveolar/large nested, thick trabecular/insular, papillary/pseudopapillary patterns; category 3: characterized by scattered vascularity without a vascular network, including solid sheets, rhabdoid and sarcomatoid patterns. Adverse pathological prognostic factors such as TNM stage, WHO/ISUP grade, and necrosis were significantly associated with category 3, followed by category 2 (all p < 0.001). We successfully validated the classification using The Cancer Genome Atlas (TCGA) cohort (n = 162), and RNA-sequencing data available from TCGA showed that the angiogenesis gene signature was significantly enriched in category 1 compared to categories 2 and 3, whereas the immune gene signature was significantly enriched in category 3 compared to categories 1 and 2. In univariate analysis, vascularity-based architectural classification showed the best accuracy in pathological prognostic factors for predicting recurrence-free survival (c-index = 0.786). The predictive accuracy of our model which integrated WHO/ISUP grade, necrosis, TNM stage, and vascularity-based architectural classification was greater than conventional risk models (c-index = 0.871 vs. 0.755-0.843). Our findings suggest that the vascularity-based architectural classification is prognostically useful and may help stratify patients appropriately for management based on their likelihood of post-surgical recurrence.
© 2021. The Author(s), under exclusive licence to United States & Canadian Academy of Pathology.

Entities:  

Mesh:

Year:  2021        PMID: 34848832     DOI: 10.1038/s41379-021-00982-9

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  32 in total

Review 1.  Understanding pathologic variants of renal cell carcinoma: distilling therapeutic opportunities from biologic complexity.

Authors:  Brian Shuch; Ali Amin; Andrew J Armstrong; John N Eble; Vincenzo Ficarra; Antonio Lopez-Beltran; Guido Martignoni; Brian I Rini; Alexander Kutikov
Journal:  Eur Urol       Date:  2014-05-21       Impact factor: 20.096

2.  Clinical impact of segmental renal vein invasion on recurrence in patients with clinical T1 renal cell carcinoma undergoing partial nephrectomy.

Authors:  Takashi Yoshida; Chisato Ohe; Toyonori Tsuzuki; Motohiko Sugi; Hidefumi Kinoshita; Koji Tsuta; Tadashi Matsuda
Journal:  Int J Clin Oncol       Date:  2019-09-17       Impact factor: 3.402

Review 3.  Data set for the reporting of carcinoma of renal tubular origin: recommendations from the International Collaboration on Cancer Reporting (ICCR).

Authors:  Brett Delahunt; John R Srigley; Meagan J Judge; Mahul B Amin; Athanase Billis; Philippe Camparo; Andrew J Evans; Stewart Fleming; David F Griffiths; Antonio Lopez-Beltran; Guido Martignoni; Holger Moch; John N Nacey; Ming Zhou
Journal:  Histopathology       Date:  2019-02       Impact factor: 5.087

4.  Architectural Patterns are a Relevant Morphologic Grading System for Clear Cell Renal Cell Carcinoma Prognosis Assessment: Comparisons With WHO/ISUP Grade and Integrated Staging Systems.

Authors:  Jérôme Verine; Delphine Colin; Mary Nheb; Dominique Prapotnich; Guillaume Ploussard; Xavier Cathelineau; François Desgrandchamps; Pierre Mongiat-Artus; Jean-Paul Feugeas
Journal:  Am J Surg Pathol       Date:  2018-04       Impact factor: 6.394

Review 5.  Renal Cell Tumors: Molecular Findings Reshaping Clinico-pathological Practice.

Authors:  Maria S Tretiakova
Journal:  Arch Med Res       Date:  2020-08-21       Impact factor: 2.235

6.  Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials.

Authors:  Bradley C Leibovich; Michael L Blute; John C Cheville; Christine M Lohse; Igor Frank; Eugene D Kwon; Amy L Weaver; Alexander S Parker; Horst Zincke
Journal:  Cancer       Date:  2003-04-01       Impact factor: 6.860

7.  A novel machine learning approach reveals latent vascular phenotypes predictive of renal cancer outcome.

Authors:  Nathan Ing; Fangjin Huang; Andrew Conley; Sungyong You; Zhaoxuan Ma; Sergey Klimov; Chisato Ohe; Xiaopu Yuan; Mahul B Amin; Robert Figlin; Arkadiusz Gertych; Beatrice S Knudsen
Journal:  Sci Rep       Date:  2017-10-16       Impact factor: 4.379

8.  Ontological analyses reveal clinically-significant clear cell renal cell carcinoma subtypes with convergent evolutionary trajectories into an aggressive type.

Authors:  Qi Cai; Alana Christie; Satwik Rajaram; Qinbo Zhou; Ellen Araj; Suneetha Chintalapati; Jeffrey Cadeddu; Vitaly Margulis; Ivan Pedrosa; Dinesh Rakheja; Renee M McKay; James Brugarolas; Payal Kapur
Journal:  EBioMedicine       Date:  2019-12-16       Impact factor: 8.143

9.  The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma.

Authors:  Christopher J Ricketts; Aguirre A De Cubas; Huihui Fan; Christof C Smith; Martin Lang; Ed Reznik; Reanne Bowlby; Ewan A Gibb; Rehan Akbani; Rameen Beroukhim; Donald P Bottaro; Toni K Choueiri; Richard A Gibbs; Andrew K Godwin; Scott Haake; A Ari Hakimi; Elizabeth P Henske; James J Hsieh; Thai H Ho; Rupa S Kanchi; Bhavani Krishnan; David J Kwiatkowski; Wembin Lui; Maria J Merino; Gordon B Mills; Jerome Myers; Michael L Nickerson; Victor E Reuter; Laura S Schmidt; C Simon Shelley; Hui Shen; Brian Shuch; Sabina Signoretti; Ramaprasad Srinivasan; Pheroze Tamboli; George Thomas; Benjamin G Vincent; Cathy D Vocke; David A Wheeler; Lixing Yang; William Y Kim; A Gordon Robertson; Paul T Spellman; W Kimryn Rathmell; W Marston Linehan
Journal:  Cell Rep       Date:  2018-04-03       Impact factor: 9.423

10.  Features of increased malignancy in eosinophilic clear cell renal cell carcinoma.

Authors:  Helén Nilsson; David Lindgren; Håkan Axelson; Christian Brueffer; Lao H Saal; Jaana Lundgren; Martin E Johansson
Journal:  J Pathol       Date:  2020-09-24       Impact factor: 7.996

View more
  3 in total

1.  Histologic-Based Tumor-Associated Immune Cells Status in Clear Cell Renal Cell Carcinoma Correlates with Gene Signatures Related to Cancer Immunity and Clinical Outcomes.

Authors:  Chisato Ohe; Takashi Yoshida; Junichi Ikeda; Toyonori Tsuzuki; Riuko Ohashi; Haruyuki Ohsugi; Naho Atsumi; Ryosuke Yamaka; Ryoichi Saito; Yoshiki Yasukochi; Koichiro Higasa; Hidefumi Kinoshita; Koji Tsuta
Journal:  Biomedicines       Date:  2022-01-29

2.  PBRM1 Immunohistochemical Expression Profile Correlates with Histomorphological Features and Endothelial Expression of Tumor Vasculature for Clear Cell Renal Cell Carcinoma.

Authors:  Kazuho Saiga; Chisato Ohe; Takashi Yoshida; Haruyuki Ohsugi; Junichi Ikeda; Naho Atsumi; Yuri Noda; Yoshiki Yasukochi; Koichiro Higasa; Hisanori Taniguchi; Hidefumi Kinoshita; Koji Tsuta
Journal:  Cancers (Basel)       Date:  2022-02-20       Impact factor: 6.639

3.  Updating Clear Cell Renal Cell Carcinoma (a Tribute to Prof. Ondrej Hes).

Authors:  Claudia Manini; José I López
Journal:  Cancers (Basel)       Date:  2022-08-18       Impact factor: 6.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.